Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

Biochemistry Referrals - UHC

Gateshead Health NHS Foundation Trust · compiled

Tender information last checkedLast checked 30 Sept 2026, 06:18.

Opportunity overview

Biochemistry referral testing.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Classification

  • CPV85145000 — Services provided by medical laboratories

Lots

  • This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 29th July 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR process C. Services required: Biochemistry referral testing as and when required. Contract Value: £7500 Contract period: 2025 - 2028Value not stated

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
ocds-h6vhtk-056249
Status
complete
Procurement Method
limited
Main Procurement Category
services
Procurement Method Details
Award procedure without prior publication of a call for competition
Why this procedure was chosen
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 29th July 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Amendments

Entry 1
Id
1

Unstructured Changes

Entry 1

Where

Section
VI.3

New Value

Text
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 4th August 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Decision Makers: Dr David Kennedy Conflicts of Interest: None declared Clinical criteria: Suitable / compatible analytical methodology, appropriate reference ranges and clinical comments, availability of useful clinical advice (based on national reputation, and/or experience and/or user feedback) UKAS Accredited (or ETS applied for and pending assessment)

Old Value

Text
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not appl to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 29th July 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Decision makers: Dr Kate MacDougall Conflicts of Interest: None declared Clinical Criteria: Second Opinion are requested from experts in a chosen speciality that are employed in a UKAS accredited laboratory and participate in EQA for that speciality. Turnaround times for results are also a consideration for utilising the referral service with this provider. Test referrals are made to UKAS accredited laboratories with acceptable clinical interpretation, availability of clinical advice and turnarounds that facilitate compliance with RCPath guidelines. Referrals are often made in accordance with established regional referral pathways in line with MDT arrangements for tertiary specialities. Genomic test referrals are made in accordance with genomic hub guidelines. Rationale: Existing service provider, will likely satisfy the proposed contract to a sufficient standard. No considerable changes anticipated.
Entry 2
Id
2
Description
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. This contract has now been formally awarded using direct award process C. Contract Award date: 18.07.25 Services to be provided between: 01.04.25 - 31.03.28 Contract value: £7500

Legal basis

Id
32014L0024
Scheme
CELEX

Classification

Id
85145000
Scheme
CPV
Description
Services provided by medical laboratories

Procedure reasons

Entry 1
Id
D_OUTSIDE_SCOPE
Scheme
TED_PT_AWARD_CONTRACT_WITHOUT_CALL
Description
The procurement falls outside the scope of application of the directive

Lots and requirements

Entry 1
Id
1
Status
cancelled
Has Options
No
Description
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 29th July 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR process C. Services required: Biochemistry referral testing as and when required. Contract Value: £7500 Contract period: 2025 - 2028

Award criteria

Criteria

Criterion 1
Name
he existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard
Type
cost
Description
100

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery locations

Entry 1
Region
UK

Buyer, suppliers and contacts

Organisation 1
Id
GB-FTS-148412
Name
Gateshead Health NHS Foundation Trust

Roles

buyer

Address

Region
UKC22
Locality
Gateshead
Postal Code
NE96SX
Country Name
United Kingdom
Street Address
Queen Elizabeth Hospital, Sheriff Hill

Details

Classifications

Entry 1
Id
REGIONAL_AUTHORITY
Scheme
TED_CA_TYPE
Description
Regional or local authority
Entry 2
Id
07
Scheme
COFOG
Description
Health

Identifier

Legal Name
Gateshead Health NHS Foundation Trust
No Identifier Rationale
notOnAnyRegister

Contact

Telephone
+44 1914452801
Organisation 2
Id
GB-FTS-155069
Name
Cambridge University Hospital NHS Trust

Roles

supplier

Address

Region
UK
Locality
Cambridge
Country Name
United Kingdom

Details

Scale
large

Identifier

Legal Name
Cambridge University Hospital NHS Trust
No Identifier Rationale
notOnAnyRegister
Organisation 3
Id
GB-FTS-132424
Name
PSR Review Panel

Roles

reviewBody

Address

Locality
London
Country Name
United Kingdom

Identifier

Legal Name
PSR Review Panel

Award information

Award 1
Id
041383-2025-1
Status
active

Suppliers

Supplier 1
Id
GB-FTS-155069
Name
Cambridge University Hospital NHS Trust

Related lots

1

Contracts and changes

Entry 1
Id
041383-2025-1
Status
active
Award ID
041383-2025-1
Date Signed
17 Jul 2025, 00:00

Value

Amount
7,500
Currency
GBP

Recorded locations

  • Buyer location · Gateshead · UKC22 · NE96SX · United Kingdom
  • Delivery location · UK

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-056249-2025-08-06T12:35:12+01:00compiled ·